Charter Oak Capital Management, LLC Novavax Inc Transaction History

Charter Oak Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	BUY	$69.73 - $142.9 $5,648 - $11,574	81 Added 26.47%	387 $29,000
Q4 2021 Feb 09, 2022	BUY	$134.56 - $217.97 $36,062 - $58,415	268 Added 705.26%	306 $44,000
Q1 2021 May 17, 2021	BUY	$112.98 - $319.93 $3,502 - $9,917	31 Added 442.86%	38 $7,000
Q4 2020 Feb 12, 2021	BUY	$78.74 - $139.5 $551 - $976	7 New	7 $1,000

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Charter Oak Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Charter Oak Capital Management, LLC with notifications on news.